drugset / Trial / NCT00319111
Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The present trial investigates the long-term safety, tolerability and efficacy of bosentan in patients with inoperable CTEPH.
Timeline
- Start
- 2006-01
- Primary completion
- 2009-02
- Completion
- 2009-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bosentan | Other / unclassified | 62.5 mg | Oral |
| Subject | Bosentan | Other / unclassified | 125 mg | Oral |